Tumor Biology

, Volume 33, Issue 5, pp 1629–1637 | Cite as

Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario

  • Arshad A. Pandith
  • Mushtaq A. Siddiqi
Research Article


Cancer is a major burden worldwide but there are marked geographical variations in frequency and incidence overall. The aim of this study was to find the frequency and distribution of commonly occurring cancers in Kashmir, with particular emphasis on urinary bladder cancer. A total of 4,407 cases of histologically confirmed new cancer cases were registered at the Medical Records Department (MRD) of SKIMS from a period between January, 2005 and April 2010. Among 4407 cancers, 2,457 (55.7 %) were men and 1,950 (44.3 %) were women. Stomach cancer is the leading one with an average frequency of 19.2 % followed by esophagus and lung as 16.5 % and 14.6 %, respectively. Stomach (23 %) and lung (21 %) are the leading cancers in men while as esophageal cancer tops (18.3 %) in women followed by breast cancer (16.6 %). This distribution of cancer types is strikingly different from that in the rest of India where oropharyngeal cancer is most common form. Among urinogenital cancers, bladder cancer was observed to primarily affect Kashmiri population (5.9 %) followed by prostate cancer (2.1 %) and renal carcinoma (1.1 %). We conclude that Kashmir is a very high risk area of most commonly occurring cancers particularly cancers of gastrointestinal tract which comprise more than half the frequency of all the cancers.


Bladder cancer Oropharyngeal cancer Kashmiri population Gastrointestinal tract Genetic factors 



I acknowledge the assistance of the Department of Medical Records, SKIMS particularly Mohammad Yousuf who helped me in collection of the data and Ms Nighat Khan, Mr Niyaz Azad and Mohsin Saleem for their valuable inputs.


  1. 1.
    Garcia M, Jemal A, Ward EM, et al. Global cancer facts and figures 2007. American Cancer Society, Atlanta.Google Scholar
  2. 2.
    Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5.version 2.0. Lyon: IARC Press; 2004.Google Scholar
  3. 3.
    Boyle P, Levin B, editors. World Cancer Report 2008. Lyon: International Agency for Research on Cancer; 2008.Google Scholar
  4. 4.
    Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine. 2006;3(11):e442.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Nanda KA. Consolidated report of the population based cancer registries, incidence and distribution of cancer, 1990–1996. National Cancer Registry Program, New Delhi: Indian Council of Medical research; 2001.Google Scholar
  6. 6.
    World Health Organization. A decade of health development in SE Asia, 1968–1977. New Delhi: SEARO; 1978.Google Scholar
  7. 7.
    IARC. Schistosomes, liver flukes and Helicobacter pylori, IARC monographs, vol. 61. Lyon: IARC; 1994.Google Scholar
  8. 8.
    Kmet J, Mahboubi E. Gesophageal cancer in the Caspian littoral of Iran: initial studies. Science. 1972;175:846–52.CrossRefPubMedGoogle Scholar
  9. 9.
    Yang CS. Research on oesophageal cancer in China: a review. Cancer Res. 1980;40:2633–44.PubMedGoogle Scholar
  10. 10.
    Warwick GP. Some aspects of the epidemiology and aetiology of esophageal cancer with particular emphasis on the Transkei, South Africa. Adv Cancer Res. 1973;17:81–229.CrossRefGoogle Scholar
  11. 11.
    Siddiqi M, Preussmann R. Oesophageal cancer in Kashmir—an assessment. J Cancer Res Clin Oncol. 1989;115:111–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Malhotra SL. Geographical distribution of gastrointestinal cancers in India with special reference to causation. Gut. 1967;8:361–72.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tricker AR, Siddiqi M, Preussmann R. Occurrence of volatile N-nitrosoamines in dried chillies. Cancer Leu. 1988;38:271–3.CrossRefGoogle Scholar
  14. 14.
    Siddiqi M, Tricker AR, Preussmann R. The occurrence of preformed N-nitroso compounds in food samples from a high risk area of esophageal cancer in Kashmir, India. Cancer Leu. 1988;39:37–43.CrossRefGoogle Scholar
  15. 15.
    Waterhouse J, Shanmugaratnam K, et al. Cancer incidence in five continents. Lyon: IARC; 1982. p. 390–7. IARC Scientific Publication no 42.Google Scholar
  16. 16.
    Siddiqi M, Tricker AR, Preussmann R. Formation of N-nitroso compounds under simulated gastric conditions from Kashmir food stuffs. Cancer Leu. 1988;39:259–65.CrossRefGoogle Scholar
  17. 17.
    Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents, vol. VII, International Agency for Research on Cancer (IARC). Lyon: IARC; 1997.Google Scholar
  18. 18.
    Koul PA, Koul SK. Epidemiology of lung cancer in Kashmir Valley. Annuals of Thoracic Medicine. Thesis submitted to the Sheri Kashmir Institute of Medical Sciences University; 2007.Google Scholar
  19. 19.
    Khan NA, Firafroz, Lone MM, et al. Profile of lung cancer in Kashmir India. A five year study. Indian J Chest Dis and Allied Sci. 2006;48:185–8.Google Scholar
  20. 20.
    Behera D, Balamugesh T. Lung cancer in India. Indian J Chest Dis and allied Sci. 2004;46:269–81.Google Scholar
  21. 21.
    Ernest LW, Kiychiko M, Edward JB. The epidemiology of lung cancer. JAMA. 1970;213:2221–7.CrossRefGoogle Scholar
  22. 22.
    Wynder EL, Munskinski M. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer. 1977;40:1872–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Taylor J, Piper DW. The carcinogenic effect of cigarette smoke. The effect of cigarette smoke on human gastric mucosal cell in organ cultures. Cancer. 1971;39:2520.CrossRefGoogle Scholar
  24. 24.
    Arya SN, Kumar R, Snajay A. Hazards of smoking. Indian Med Assoc. 1991;89:98–100.Google Scholar
  25. 25.
    Karim-Kos HE, De Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–89.CrossRefPubMedGoogle Scholar
  26. 26.
    Clavel J. Progress in the epidemiological understanding of gene environment interactions in major diseases: cancer. C R Biol. 2007;330:306–17.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Arshad AP, Zafar S, Roohi R, et al. Activated H-ras gene mutations in transitional cell carcinoma of urinary the bladder in a Kashmiri population. Tumori. 2010;96:993–8.Google Scholar
  28. 28.
    Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality, International Agency for Research on Cancer (IARC), Scientific Publication 121. Lyon: IARC; 1993.Google Scholar
  29. 29.
    Neve A. Kangri-bum epithelioma in Kashmir. Ind Med Gaz. 1990;35:81–3.Google Scholar
  30. 30.
    Neve EF. Kangri bum cancer. Br Med J. 1923;2:1255–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Neve EF. Kangri-bum cancer. Ind Med Gaz. 1941;76:138–40.Google Scholar
  32. 32.
    Shera AH, Bhan BM. Clinicopathological behavior of Kangri cancer. Ind J Surg. 1986;48:233–8.Google Scholar
  33. 33.
    Sanyal B, Shastri SR, Hakim A, et al. A clinical profile of skin cancer from Kashmir valleywith special reference to “Kangri” cancer. J Clin Radiother Oncol. 1989;4:31–6.Google Scholar
  34. 34.
    Treves N, Pack GT. The development of cancer in bum scars. Surg Gynecol Obstet. 1930;51:749–82.Google Scholar
  35. 35.
    Perin N, Notani. Global variation in cancer incidence and mortality. Current Science. 2001;81(5):465–74.Google Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2012

Authors and Affiliations

  1. 1.Departments of Immunology and Molecular MedicineSher-I-Kashmir Institute of Medical SciencesSrinagarIndia

Personalised recommendations